Authors


Marie-josee Lynch, MD

Latest:

Medical Marijuana: Regulations Surrounding Its Use

Disparate means of accessing marijuana complicates the evaluation of the quality, purity, and potency of cannabis.


Marilyn Price, MD

Latest:

Firearms and Mental Illness

While violence is often portrayed in the media as related to persons with mental illnesses, there are limited research data to support this idea. This article reviews laws and obligations for mental health professionals.


Mario A. Cristancho, MD

Latest:

Atypical Depression in the 21st Century: Diagnostic and Treatment Issues

Identification of atypical features is important in the treatment of depression for both treatment selection and prognosis, especially when initial measures prove ineffective. The concept of atypical depression has evolved over many years, and now it appears timely for a further revision.


Mario Cappelli, PhD

Latest:

The HEADS-ED: Review of a Mental Health Screening Tool for Pediatric Patients

A new screening tool based on the previously developed mnemonic designed to assist physicians with obtaining a psychosocial history from adolescents as part of a routine visit was developed by researchers at the Children’s Hospital of Eastern Ontario.


Mario Maj, MD, PhD

Latest:

Rapid Cycling in Bipolar Disorder: Diagnostic Issues and Treatment Options

A discussion of the many difficulties in treating patients with the rapid-cycling subtype of bipolar disorder, along with a history of the condition and the author’s treatment approach.


Marion C. Eakin, MD

Latest:

Parenteral Antidepressants: Is America Ready?

In spite of the enormous success of antidepressants, there are surprisingly few that are available in other than oral form. There is now substantial evidence that intravenous administration is well tolerated and may accelerate onset of therapeutic effect. With the possibility of transdermal delivery3/4a noninvasive and painless route of administration requiring no technical support3/4parenteral antidepressants may become more acceptable in this country and warrant further clinical investigation.


Marion K. Jenkins, PhD, FHIMSS

Latest:

Germs and Viruses: The Other Kind

Is your practice’s computer infected? Perhaps, but that stack of papers on your desk might have a richer history of contamination.


Marion Sherman, MD

Latest:

Adaptation and Implementation of the Integrated Dual Diagnosis Treatment Model Into a Psychiatric Inpatient Facility: A 12-Year Perspective

As early as the 1970s, researchers and practitioners became increasingly aware of the necessity for services that would address the varied needs and treatment implications for consumers with the co-occurring disorders of substance abuse and mental illness. High percentages of consumers in substance abuse treatment centers were identified with mental illness disorders, and consumers admitted to psychiatric facilities often were identified as having additional substance use disorders.


Marion Zucker Goldstein, MD

Latest:

Overview of Elder Maltreatment

As the population ages, psychiatrists will need to take a more proactive role in preventing, diagnosing and treating elder abuse. This article looks at the definition of elder abuse and the history of reporting it, research findings on the effects of abuse on mortality, and needs for the future.


Marisa Torrieri

Latest:

HHS Proposed Rule Pushes ICD-10 Compliance to Oct. 1, 2014

HHS Secretary Kathleen Sebelius has announced a proposed rule that would push the compliance date for ICD-10 to Oct. 1, 2014, one year past the original date.


Marjorie Braude, MD

Latest:

Psychiatrists and Mandatory Reporting of Domestic Violence

Mandatory reporting laws rarely require reporting by psychiatrists. Psychiatrists need to treat the patient, rather than act as mandated reporters, and be knowledgeable about the dynamics and consequences of domestic violence and about available community resources and advocates that can help the patient.


Mark A. Hurst, MD

Latest:

Adaptation and Implementation of the Integrated Dual Diagnosis Treatment Model Into a Psychiatric Inpatient Facility: A 12-Year Perspective

As early as the 1970s, researchers and practitioners became increasingly aware of the necessity for services that would address the varied needs and treatment implications for consumers with the co-occurring disorders of substance abuse and mental illness. High percentages of consumers in substance abuse treatment centers were identified with mental illness disorders, and consumers admitted to psychiatric facilities often were identified as having additional substance use disorders.


Mark A. Turner, MRCP, MRCPsych, PhD

Latest:

CRPS Type I and Mental Illness

Dr Steven King provided an interesting summary of complex regional pain syndrome (CRPS) in Psychiatric Times (Complex Regional Pain Syndrome, June 2006, page 9). We felt it would be useful to provide some additional observations on the relationship between CRPS type I and psychological causes of pain.


Mark B. Hamner, MD

Latest:

The Many Faces of Posttraumatic Stress Disorder

Chronic posttraumatic stress disorder (PTSD) may occur secondary to combat, terrorism, civilian assaults including physical and sexual abuse, or other traumatic experiences.


Mark B. Ting, MD

Latest:

Managing Psychosis in Patients With Alzheimer Disease

Alzheimer disease psychosis appears to be a distinct clinical entity. This article focuses on management strategies.



Mark D. Miller, MD

Latest:

Managing Late-Life Depression With Combined Medication and Psychotherapy

There are hundreds of studies that show that pharmacotherapy is used to treat depression in adult and geriatric populations. There are far fewer studies that test the efficacy of psychotherapies and even fewer studies that focus on combined treatment for older patients.


Mark D. Wiederhold, MD, PhD

Latest:

A New Approach: Using Virtual Reality Psychotherapy in Panic Disorder With Agoraphobia

With the advent of computer technology, new forms of therapy have emerged that can help patients. How can a virtual reality environment enable patients to overcome panic disorder and agoraphobia, and what are the advantages to such forms of therapy?


Mark E. Kunik, MD, MPH

Latest:

Comorbidity: Psychiatric Comorbidity in Persons With Dementia

The assessment and treatment of psychiatric symptoms in persons with cognitive dysfunction are becoming increasingly important. Prevalence estimates of dementia in the United States range from 5% in those aged 71 to 79 years to 25% to 50% in those 90 or older.


Mark E. Larsen, DPhil

Latest:

Apps for Suicide Prevention: What the Research Says

A review of smartphone tools for suicide prevention and recommendations for clinicians.


Mark E. Servis, MD

Latest:

Drug Therapies for the Neurobehavioral Sequelae of Traumatic Brain Injury

Traumatic brain injury (TBI) is one of the most common causes of morbidity and mortality, especially in young adults. Recognition and early accurate diagnosis of neurobehavioral TBI sequelae are important in reducing the severity of postinjury symptoms. Sequelae of TBI include cognitive impairments, personality changes, aggression, impulsivity, apathy, anxiety, depression, mania, and psychosis.


Mark Eldaief, MD

Latest:

Advances in Neuroimaging: Impact on Psychiatric Practice

Neuroimaging is often used in clinical psychiatry to rule out medical and neurological conditions that can mimic psychiatric disease rather than for the diagnosis of specific psychiatric disorders.


Mark Frankel, MD

Latest:

Neuropsychiatry: Toward Solving the Mysteries That Animate Psychiatry

How do meaning, memory, emotions and, especially, human suffering arise from the brain?


Mark Green, MD

Latest:

The Truth About Marijuana

An interesting history, key myths, and the pros and cons of marijuana are explained in this book.


Mark H. Lewis, PhD

Latest:

Psychopharmacology of Autism Spectrum Disorders

Autism is a highly prevalent, highly heterogeneous disorder of unknown etiology. Studies to clearly establish the efficacy of various classes of psychoactive drugs are scarce. Nonetheless, available findings do support the efficacy of atypical antipsychotics and antidepressants in treating the core symptoms of repetitive behavior.


Mark Ilgen, PhD

Latest:

The Link Between Substance Abuse, Violence, and Suicide

Emerging research suggests that some individuals with particular types of substance use and abuse may be more likely to engage in suicidal behaviors. For example, those who use opiates, cocaine, or sedatives may have a noticeably higher risk of suicide than those who use other drugs.


Mark J. Albanese, MD

Latest:

SUBSTANCE ABUSE AND ADDICTION Advances and Challenges in Addiction Medicine

Recent years have witnessed exciting developments in understanding and treating addictions. For example, it seems that almost weekly we get new insights into the neurobiology underlying vulnerability to addiction. Similarly, there have never been more medications available to treat the spectrum of addictive disorders, especially alcohol, nicotine, and opioid dependence. In addition, studies continue to underscore the crucial role of psychosocial treatments in recovery from addiction.


Mark J. Goldblatt, MD

Latest:

Psychopharmacological Treatment to Reduce Suicide Risk

Adequate treatment of the underlying psychiatric illness consistently appears to be the most effective use of medication in suicidal patients.


Mark J. Niciu Jr, MD, PhD

Latest:

Alcohol Disorders: Practical Tips From New Research

In this review, we discuss the established medications as well as experimental therapeutic options that may emerge as future medications for alcohol intoxication, withdrawal, and/or long-term abstinence maintenance or harm-reduced drinking.


Mark L. Fuerst

Latest:

Brain Health in Aging Adults

Three studies highlight sedentary behavior and memory, cognitive decline in psychosis, and risk of dementia with anticholinergic drugs.

© 2024 MJH Life Sciences

All rights reserved.